Advanced in Short-Chain Acyl-CoA Dehydrogenase Deficiency

Damien Bouvier

Clermont-ferrand, FR 
Advanced in Short-Chain Acyl-CoA Dehydrogenase Deficiency
Clermont-ferrand, FR 
OverviewLocationsClinical Research

Overview

Damien Bouvier practices in Clermont-ferrand, France. Mr. Bouvier is rated as an Advanced expert by MediFind in the treatment of Short-Chain Acyl-CoA Dehydrogenase Deficiency. His top areas of expertise are Concussion, Acute Respiratory Distress Syndrome (ARDS), Traumatic Brain Injury, Colonoscopy, and Endoscopy.

His clinical research consists of co-authoring 98 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Short-Chain Acyl-CoA Dehydrogenase Deficiency.

Gender
Male

Locations

Clermont-ferrand, France
Other Locations
29, Rue Manin, 75940 Paris Cedex 19, Paris, 75940, France
CHU Clermont Ferrand, Clermont
Ferrand, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Usefulness of Biomarkers in the Management of Mild Traumatic Brain Injury in Adults
Usefulness of Biomarkers in the Management of Mild Traumatic Brain Injury in Adults
Enrollment Status: Completed
Publish Date: October 08, 2024
Study of the Inappropriate Secretion of FGF23 in Patients Followed in Hospital in a Context of Hypophosphatemia
Study of the Inappropriate Secretion of FGF23 in Patients Followed in Hospital in a Context of Hypophosphatemia
Enrollment Status: Completed
Publish Date: May 11, 2023
Intervention Type: Behavioral
Interventional Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury
Interventional Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury
Enrollment Status: Completed
Publish Date: January 05, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
View 2 Less Clinical Trials

98 Total Publications

Performance of GFAP and UCH-L1 compared to S100B in detecting intracranial injury: influence of age, hemolysis, neurodegenerative diseases, and extracranial fractures in a prospective cohort of over 1,000 patients.
Performance of GFAP and UCH-L1 compared to S100B in detecting intracranial injury: influence of age, hemolysis, neurodegenerative diseases, and extracranial fractures in a prospective cohort of over 1,000 patients.
Journal: Clinical chemistry and laboratory medicine
Published: August 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bouvier's expertise for a condition
ConditionClose
      View All 27 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile